Company Overview
Epidarex Capital Partners Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Friday 30 November 2012, so this is a well established company. Epidarex Capital Partners Limited has been in business for 13 years and 4 months. The accounts status is unaudited abridged and the accounts are next due on Thursday 31 December 2026.
Registered Address

137A George Street, Edinburgh, EH2 4JY
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameEPIDAREX CAPITAL PARTNERS LIMITED
Company NumberSC437985
Registered Office Address137a George Street
 EH2 4JY
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date30/11/2012
Accounting Reference Date Day31
Accounting Reference Date Month3
Accounts Next Due Date31/12/2026
Accounts Last Made Up Date31/03/2025
Accounts Account CategoryUNAUDITED ABRIDGED
Returns Next Due Date28/12/2016
Returns Last Made Up Date30/11/2015
Previous Company NameChanged Date
ROCK SPRING VENTURES GP LIMITED27 Jan 2014
Directors & Members
Andrew Dunlop - Director
(British, 54 years old, born March 1972)
Appointed 30 November 2012
 Active
Peter Finan - Director
(British, 59 years old, born July 1967)
Appointed 17 June 2019
 Active
Elizabeth Roper - Director
(Irish, 52 years old, born July 1974)
Appointed 01 October 2013
 Active
Kyparissia Sirinakis - Director
(American, 61 years old, born June 1965)
Appointed 30 November 2012
 Active
Secretaries
No Secretaries Appointed
Other Company Directorships
Andrew Dunlop
EPIDAREX CAPITAL CP, LLP
EPIDAREX CAPITAL FP, LLP
EPIDAREX CAPITAL MANAGEMENT LLP
Peter Finan
ADORX THERAPEUTICS LIMITED
BIOINDUSTRY ASSOCIATION
CALDAN THERAPEUTICS LIMITED
CLYDE BIOSCIENCES LIMITED
CURVE THERAPEUTICS LIMITED
ENTERPRISE THERAPEUTICS HOLDINGS LIMITED
ENTERPRISE THERAPEUTICS LTD
EPIDAREX EXEED LIMITED
EPIDAREX MANAGEMENT LTD
EPSILOGEN LTD
ETERNYGEN UK LTD.
KINSENSUS LIMITED
KNOWLEDGE TRANSFER NETWORK LIMITED
LARIO THERAPEUTICS LIMITED
LEUCID BIO LTD
LUNAC THERAPEUTICS LIMITED
NUTHURST FIBRE PROJECT LTD
THEOLYTICS LTD
THERAVIEW CONSULTING LTD
TMEM16A LIMITED
Elizabeth Roper
EDINBURGH MOLECULAR IMAGING LIMITED
ENTERPRISE THERAPEUTICS LTD
EPIDAREX CAPITAL CP, LLP
EPIDAREX CAPITAL FP, LLP
EPIDAREX CAPITAL MANAGEMENT LLP
Kyparissia Sirinakis
EPIDAREX CAPITAL CP, LLP
EPIDAREX CAPITAL FP, LLP
EPIDAREX CAPITAL MANAGEMENT LLP
EPIDAREX MANAGEMENT LTD
EPIDAREX PARTNERS LIMITED
EPSILOGEN LTD
NODTHERA LIMITED
SIRAKOSS LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2022 31-Mar-2021
Balance Sheet
Fixed Assets 0 0 0
Current Assets 491,756 491,756 1,533,082
Creditors Due Within One Year 494,220 494,220 1,535,546
Working Cap -2,464 -2,464 -2,464
Total Assets Less Current Liabilities -2,464 -2,464 -2,464
Long-term Liabilities 494,220 494,220 1,535,546
Net Assets -496,684 -496,684 -1,538,010
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds -496,684 -496,684 -1,538,010
Common Size Financial Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2022 31-Mar-2021
Tangible Fixed Assets - - -
Fixed Assets 0.0% 0.0% 0.0%
Stocks Inventory - - -
Debtors - - -
Cash Bank In Hand - - -
Current Assets 100.0% 100.0% 100.0%
Creditors Due Within One Year 100.5% 100.5% 100.2%
Net Current Assets Liabilities -0.5% -0.5% -0.2%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds -101.0% -101.0% -100.3%
Capital Employed - - -
Total Assets Less Current Liabilities -0.5% -0.5% -0.2%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2022 31-Mar-2021
Liquidity Ratio 1.0 1.0 1.0
Solvency Ratio 0.5 0.5 0.5
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Mar-2025 31-Mar-2022 31-Mar-2021
Assets 491,756 491,756 1,533,082
Debt 988,440 988,440 3,071,092
Net Assets/Debt -496,684 -496,684 -1,538,010

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

As at the balance sheet date current liquid assets were slightly less than short term debt. We would normally view a company broadly neutrally for this. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.As at the balance sheet date current liquid assets were slightly less than short term debt. We would normally view a company broadly neutrally for this. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.As at the balance sheet date current liquid assets were slightly less than short term debt. We would normally view a company broadly neutrally for this. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around EH2 4JY
EPIDAREX CAPITAL FP, LLP
137A GEORGE STREET, EDINBURGH, EH2 4JY
EPIDAREX CAPITAL CP, LLP
137A GEORGE STREET, 137A GEORGE STREET, EDINBURGH, EH2 4JY
EPIDAREX CAPITAL MANAGEMENT LLP
137a George Street, Edinburgh, EH2 4JY
REFORM SCOTLAND
14-18 HILL STREET, EDINBURGH, EH2 4JY
POSITIVE HELP
First Floor Office, 139 George Street, Edinburgh, EH2 4JY
NODTHERA LIMITED
13 QUEENS ROAD, ABERDEEN, EH2 4JY
ETERNYGEN UK LTD.
C/O Epidarex Capital, 137a George Street, Edinburgh, Scotland, EH2 4JY
Document Filings

There is no free data currently available to display on this company.

Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free